Literature DB >> 9580666

An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fibres in a patient with autosomal dominant cutis laxa.

M Tassabehji1, K Metcalfe, J Hurst, G S Ashcroft, C Kielty, C Wilmot, D Donnai, A P Read, C J Jones.   

Abstract

Elastin is the protein responsible for the characteristic elastic properties of many tissues including the skin, lungs and large blood vessels. Loss-of-function mutations in the elastin gene are known to cause the heart defect supravalvular aortic stenosis (SVAS). We and others have identified deletions, nonsense mutations and splice site mutations in SVAS patients that abolish the function of one elastin gene. We have now identified an elastin mutation in a patient with a completely different phenotype, the rare autosomal dominant condition cutis laxa. A frameshift mutation in exon 32 of the elastin gene is predicted to replace 37 amino acids at the C-terminus of elastin by a novel sequence of 62 amino acids. mRNA and immunoprecipitation studies show that the mutant allele is expressed. Electron microscopy of skin sections shows abnormal branching and fragmentation in the amorphous elastin component, and immunocytochemistry shows reduced elastin deposition in the elastic fibres and fewer microfibrils in the dermis. These findings suggest that the mutant tropoelastin protein is synthesized, secreted and incorporated into the elastic matrix, where it alters the architecture of elastic fibres. Interference with cross-linking would reduce elastic recoil in affected tissues and explain the cutis laxa phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580666     DOI: 10.1093/hmg/7.6.1021

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  Elastic-fiber pathologies: primary defects in assembly-and secondary disorders in transport and delivery.

Authors:  Z Urbán; C D Boyd
Journal:  Am J Hum Genet       Date:  2000-06-06       Impact factor: 11.025

Review 2.  Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix.

Authors:  C M Kielty; T J Wess; L Haston; Jane L Ashworth; M J Sherratt; C A Shuttleworth
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

3.  Decreased elastin in vessel walls puts the pressure on.

Authors:  Jeanine D'Armiento
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 4.  Progress in chronic obstructive pulmonary disease genetics.

Authors:  Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2006-07

Review 5.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

6.  Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa.

Authors:  Bert Callewaert; Chi-Ting Su; Tim Van Damme; Philip Vlummens; Fransiska Malfait; Olivier Vanakker; Bianca Schulz; Meghan Mac Neal; Elaine C Davis; Joseph G H Lee; Aicha Salhi; Sheila Unger; Ketil Heimdal; Salome De Almeida; Uwe Kornak; Harald Gaspar; Jean-Luc Bresson; Katrina Prescott; Maria E Gosendi; Sahar Mansour; Gérald E Piérard; Suneeta Madan-Khetarpal; Frank C Sciurba; Sofie Symoens; Paul J Coucke; Lionel Van Maldergem; Zsolt Urban; Anne De Paepe
Journal:  Hum Mutat       Date:  2012-08-13       Impact factor: 4.878

7.  Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency.

Authors:  Gilles Faury; Mylène Pezet; Russell H Knutsen; Walter A Boyle; Scott P Heximer; Sean E McLean; Robert K Minkes; Kendall J Blumer; Attila Kovacs; Daniel P Kelly; Dean Y Li; Barry Starcher; Robert P Mecham
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 8.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development.

Authors:  Zsolt Urban; Vishwanathan Hucthagowder; Nura Schürmann; Vesna Todorovic; Lior Zilberberg; Jiwon Choi; Carla Sens; Chester W Brown; Robin D Clark; Kristen E Holland; Michael Marble; Lynn Y Sakai; Branka Dabovic; Daniel B Rifkin; Elaine C Davis
Journal:  Am J Hum Genet       Date:  2009-10-15       Impact factor: 11.025

10.  Congenital cutis laxa.

Authors:  Anupama Mauskar; Preeti Shanbag; Varsha Ahirrao; Leena Nagotkar
Journal:  Ann Saudi Med       Date:  2010 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.